Funds tied to two Windward Bio directors buy $49.8 million of shares
Funds tied to two Windward Bio directors, OrbiMed and Omega, bought $49.8 million of its shares at $17 each on November 16, filed on November 18.
The purchases
3 insiders
Purchase on Nov 16, filed on Nov 18
3
Buyers
$69.75M
Bought
0
Sellers
Director
OS
Otello Stampacchia
Buy · $29.75M · 1,750,000 shares
OL
Orbimed Advisors LLC
Buy · $20M · 1,176,471 shares
+221.3%
DB
David P Bonita
Buy · $20M · 1,176,471 shares
+221.3%
On the right, by how much each one increased the number of shares they own. Purchases declared to the SEC, the US stock market watchdog (Form 4), decided on the spot and not scheduled in advance.
AI analysis
Nov 18
With TrueWallet Pro
Why these purchases matter given where the stock stands, and what they do not say. Upgrade to Pro from the TrueWallet app.